A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Sensex
78,151.45
▲ +1.25%
Nifty
24,334.30
▲ +1.09%
22k Gold
₹ 13,065/gm
Silver
₹ 2,30,000/kg
Petrol
₹ 111.18
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 86.03
USD
₹ 96.28
Sensex
78,151.45
▲ +1.25%
Nifty
24,334.30
▲ +1.09%
22k Gold
₹ 13,065/gm
Silver
₹ 2,30,000/kg
Petrol
₹ 111.18
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 86.03
USD
₹ 96.28
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
92.57% ↑
NAV (₹) on 16 Jul 2026
39.94
1 Day NAV Change
0.05%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
20 Jun 2019
Min. Lumpsum Amount
₹ 500
Fund Age
7 Yrs
AUM
₹ 1,010.54 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.01%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,010.54 Cr
Equity
587.3%
Money Market & Cash
12.91%
Other Assets & Liabilities
0.17%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 74.57% |
| Hospitals & Medical Services | 20.05% |
| Treps/Reverse Repo | 2.26% |
| Chemicals - Speciality | 1.44% |
| Insurance Distributor | 0.95% |
| Chemicals - Organic - Benzene Based | 0.85% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 12.09% | ₹ 122.19 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 7.30% | ₹ 73.74 | Hospitals & Medical Services |
| J.B. Chemicals & Pharmaceuticals Limited | 4.71% | ₹ 47.64 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 4.68% | ₹ 47.33 | Pharmaceuticals |
| Aurobindo Pharma Limited | 4.55% | ₹ 45.98 | Pharmaceuticals |
| Ajanta Pharmaceuticals Limited | 4.38% | ₹ 44.26 | Pharmaceuticals |
| Mankind Pharma Ltd | 3.92% | ₹ 39.60 | Pharmaceuticals |
| Lupin Limited | 3.74% | ₹ 37.79 | Pharmaceuticals |
| SAI Life Sciences Ltd | 3.50% | ₹ 35.36 | Pharmaceuticals |
| Abbott India Limited | 3.26% | ₹ 32.90 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd | 3.23% | ₹ 32.64 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.21% | ₹ 32.44 | Hospitals & Medical Services |
| Cipla Limited | 2.93% | ₹ 29.62 | Pharmaceuticals |
| IPCA Laboratories Limited | 2.55% | ₹ 25.78 | Pharmaceuticals |
| Gland Pharma Limited | 2.48% | ₹ 25.08 | Pharmaceuticals |
| Shilpa Medicare Ltd | 2.41% | ₹ 24.35 | Pharmaceuticals |
| CORONA Remedies Ltd | 2.28% | ₹ 23.01 | Pharmaceuticals |
| Clearing Corporation of India Limited | 2.26% | ₹ 22.82 | Others |
| Procter & Gamble Health Limited | 2.20% | ₹ 22.27 | Pharmaceuticals |
| Alkem Laboratories Limited | 1.93% | ₹ 19.52 | Pharmaceuticals |
| Thyrocare Technologies Limited | 1.93% | ₹ 19.48 | Hospitals & Medical Services |
| Jupiter Life Line Hospitals Ltd | 1.85% | ₹ 18.67 | Hospitals & Medical Services |
| Divi's Laboratories Limited | 1.69% | ₹ 17.11 | Pharmaceuticals |
| Dr. Lal Path Labs Limited | 1.59% | ₹ 16.09 | Hospitals & Medical Services |
| METROPOLIS HEALTHCARE LIMITED | 1.44% | ₹ 14.51 | Hospitals & Medical Services |
| SANOFI CONSUMER HEALTHCARE | 1.44% | ₹ 14.51 | Chemicals - Speciality |
| Dr. Reddys Laboratories Limited | 1.33% | ₹ 13.43 | Pharmaceuticals |
| Pfizer Limited | 1.23% | ₹ 12.46 | Pharmaceuticals |
| Biocon Limited | 1.12% | ₹ 11.36 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LIMITED | 1.08% | ₹ 10.92 | Pharmaceuticals |
| Piramal Pharma Ltd | 1.06% | ₹ 10.72 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 1.05% | ₹ 10.58 | Hospitals & Medical Services |
| Medi Assist Healthcare Services Ltd | 0.95% | ₹ 9.56 | Insurance Distributor |
| Suraksha Diagnostic Ltd | 0.90% | ₹ 9.14 | Hospitals & Medical Services |
| Vinati Organics Limited | 0.85% | ₹ 8.55 | Chemicals - Organic - Benzene Based |
| Syngene International Limited | 0.82% | ₹ 8.31 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 0.79% | ₹ 7.94 | Pharmaceuticals |
| Max Healthcare Institute Limited | 0.78% | ₹ 7.90 | Hospitals & Medical Services |
| Jubilant Pharmova Ltd | 0.61% | ₹ 6.13 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 16.24% | 16.58% | 13.51% | 24.41% |
| Category returns | 3.38% | 4.52% | 6.23% | 22.69% |
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Details
Name
Aditya Birla Sun Life AMC Limited
Date of Incorporation
23 Dec 1994
CEO
Mr. A Balasubramanian
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
One World Center, Tower 1, 17th Floor,
Jupiter Mills,
Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India - 400013
Website
https://mutualfund.adityabirlacapital.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.93 | 16.75% | 171.42% | 0.00% | ₹10,529 | 1.80% |
Very High
|
Top Funds from Aditya Birla Sun Life AMC Limited
FAQs
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹39.94 as of 16 Jul 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹1,010.54 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has delivered returns of 16.58% (1 Year), 24.41% (3 Year), 14.81% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
ವಿದೇಶಿ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರೇ ಗಮನಿಸಿ: ಹೊಸ ಎಸ್ಐಪಿ ನೋಂದಣಿ ಸ್ಥಗಿತ, ನಿಮ್ಮ ಹಣದ ಮೇಲೆ ಪರಿಣಾಮವೇನು? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರೇ ಎಚ್ಚರ! ಜುಲೈ 13ರಿಂದ ಬದಲಾಗಲಿದೆ ಎಕ್ಸ್ಪೆನ್ಸ್ ರೇಶಿಯೋ, ನಿಮ್ಮ ಲಾಭಕ್ಕೆ ಕತ್ತರಿ ಬೀಳುತ್ತಾ? -
ಎಸ್ಐಪಿ ಹೂಡಿಕೆಯಲ್ಲಿ ಹೊಸ ದಾಖಲೆ: ನಿಮ್ಮ ಹಣವನ್ನು ಎಲ್ಲಿ ಹೂಡಿಕೆ ಮಾಡಿದರೆ ಹೆಚ್ಚು ಲಾಭ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆಯಲ್ಲಿ ಹೊಸ ಇತಿಹಾಸ: ಜೂನ್ 2026ರಲ್ಲಿ ಎಸ್ಐಪಿ ಹರಿವು ₹25,000 ಕೋಟಿ ದಾಟಿದೆ! -
ಹೂಡಿಕೆದಾರರಿಗೆ ಹೊಸ ಅವಕಾಶ: TRUSTMF ಲಾರ್ಜ್ ಮತ್ತು ಮಿಡ್ ಕ್ಯಾಪ್ ಫಂಡ್ ಎನ್ಎಫ್ಒ ಆರಂಭ! -
HDFC ನಿಫ್ಟಿ ಆಟೋ ಇಂಡೆಕ್ಸ್ ಫಂಡ್ NFO: ಇಂದೇ ಕೊನೆಯ ದಿನ, ಹೂಡಿಕೆದಾರರಿಗೆ ಸಿಗಲಿದೆ ಭರ್ಜರಿ ಲಾಭ? -
ರಥಯಾತ್ರೆ ರಜೆ: ಇಂದು ನಿಮ್ಮ ಎಸ್ಐಪಿ ಹಣ ಕಟ್ ಆಗುತ್ತಾ? ಹೂಡಿಕೆದಾರರೇ ಗಾಬರಿಯಾಗಬೇಡಿ! -
ಸೆಬಿ ಹೊಸ ನಿಯಮ: ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರಿಗೆ ಭರ್ಜರಿ ಗುಡ್ ನ್ಯೂಸ್, ನಿಮ್ಮ SIP ಮೇಲೆ ಏನು ಪರಿಣಾಮ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆಯಲ್ಲಿ ನೀವು ಮಾಡುತ್ತಿರುವ ದೊಡ್ಡ ತಪ್ಪು: ಲಕ್ಷಾಂತರ ರೂಪಾಯಿ ಉಳಿಸುವುದು ಹೇಗೆ? -
ನಿಫ್ಟಿ ಸ್ಮಾಲ್ಕ್ಯಾಪ್ 250 ಎನ್ಎಫ್ಒ: ಹೂಡಿಕೆಗೂ ಮುನ್ನ ಈ ರಿಸ್ಕ್ ಬಗ್ಗೆ ನಿಮಗೆ ಗೊತ್ತಾ?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+